Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Sep-22 12:03 PM View:  | Ehrlich Leo CEO and Chairman Director | Innovation Pharmaceuticals ... (IPIX) | 28-Dec-20 | Payment of Exercise | 7,835,000 | $0.21 | $1,614,010.00 | (74%) 10.59M to 2.75M | |
| 28-Sep-22 12:06 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 11-Sep-20 | Grant | 58,394 | -- | -- | 28% 207.63K to 266.02K | |
| 28-Sep-22 12:06 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 11-Sep-20 | Payment of Exercise | 21,606 | -- | -- | (8%) 266.02K to 244.42K | |
| 28-Sep-22 12:03 PM View: | Ehrlich Leo CEO and Chairman Director | Innovation Pharmaceuticals ... (IPIX) | 23-Feb-20 | Grant | 500,000 | -- | -- | 5% 10.09M to 10.59M | |
| 28-Sep-22 11:59 AM View: | Schechter Barry A Director | Innovation Pharmaceuticals ... (IPIX) | 23-Feb-20 | Grant | 500,000 | -- | -- | 200% 250.0K to 750.0K | |
| 28-Sep-22 12:00 PM View: | Spektor Zorik Director | Innovation Pharmaceuticals ... (IPIX) | 23-Feb-20 | Grant | 500,000 | -- | -- | 2000% 25.0K to 525.0K | |
| 06-Sep-19 4:51 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-19 | Payment of Exercise | 9,619 | $0.13 | $1,250.47 | (6%) 159.85K to 150.24K | |
| 28-Sep-22 12:06 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-19 | Grant | 58,394 | -- | -- | 39% 149.24K to 207.63K | |
| 06-Sep-19 4:51 PM View: | Bertolino Arthur Peter President and CMO Director | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-19 | Payment of Exercise | 421,611 | $0.13 | $54,809.40 | (17%) 2.48M to 2.06M | |
| 16-Oct-18 4:15 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 12-Oct-18 | Payment of Exercise | 9,272 | $0.40 | $3,708.80 | (5%) 169.13K to 159.85K | |
| 15-Oct-18 6:18 PM View: | Bertolino Arthur Peter President and CMO | Innovation Pharmaceuticals ... (IPIX) | 12-Oct-18 | Payment of Exercise | 218,946 | $0.40 | $87,578.40 | (8%) 2.7M to 2.48M | |
| 24-Sep-18 4:26 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-18 | Grant | 58,394 | -- | -- | 53% 110.73K to 169.13K | |
| 24-Sep-18 4:32 PM View: | Bertolino Arthur Peter President and CMO | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-18 | Grant | 1,066,670 | -- | -- | 65% 1.63M to 2.7M | |
| 27-Dec-17 3:07 PM View: | Bertolino Arthur Peter President and CMO | Innovation Pharmaceuticals ... (IPIX) | 22-Dec-17 | Payment of Exercise | 238,048 | $0.70 | $166,634.00 | (13%) 1.87M to 1.63M | |
| 06-Sep-17 6:23 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-17 | Payment of Exercise | 6,056 | $0.71 | $4,299.76 | (5%) 116.79K to 110.73K | |
| 06-Sep-17 6:23 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-17 | Grant | 58,394 | -- | -- | 100% 58.39K to 116.79K | |
| 28-Sep-22 12:06 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-17 | Payment of Exercise | 1,000 | -- | -- | (< 1%) 150.24K to 149.24K | |
| 06-Sep-17 6:26 PM View: | Bertolino Arthur Peter Pres. & Chief Medical Officer | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-17 | Grant | 1,066,670 | -- | -- | 133% 804.58K to 1.87M | |
| 08-Aug-17 10:00 PM View: | Bertolino Arthur Peter Pres. & Chief Medical Officer | Innovation Pharmaceuticals ... (IPIX) | 27-Jun-17 | Payment of Exercise | 262,080 | $0.84 | $220,147.00 | (25%) 1.07M to 804.59K | (7%) |
| 08-Aug-17 10:00 PM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 28-Dec-16 | Gift | 1,000,000 | -- | -- | 12% 8.54M to 9.54M | |
| 08-Aug-17 10:00 PM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 28-Dec-16 | Gift | 1,200,000 | -- | -- | (13%) 9.54M to 8.34M | |
| 08-Aug-17 10:00 PM View: | Harness Jane A. Vice President | Innovation Pharmaceuticals ... (IPIX) | 01-Sep-16 | Grant | 58,394 | -- | -- | 100% 0 to 58.39K | |
| 08-Aug-17 10:00 PM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 25-Jul-16 | Gift | 50,000 | -- | -- | (< 1%) 8.59M to 8.54M | |
| 07-Jul-16 1:52 PM View: | Bertolino Arthur Peter Pres. & Chief Medical Officer | Innovation Pharmaceuticals ... (IPIX) | 30-Jun-16 | Grant | 1,066,670 | -- | -- | 100% 0 to 1.07M | |
| 18-Dec-15 12:15 PM View: | Menon Krishna President and CSO Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 30-Nov-15 | Disposition (other) | 6,000,000 | -- | -- | (29%) 21.05M to 15.05M | |
| 02-Jan-15 10:22 AM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 30-Dec-14 | Gift | 50,000 | -- | -- | (< 1%) 8.63M to 8.59M | |
| 02-Sep-14 9:21 PM View: | Menon Krishna President, CSO Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 28-Aug-14 | Disposition (other) | 10,000,000 | -- | -- | (32%) 31.05M to 21.05M | |
| 07-Jan-13 1:33 PM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 21-Dec-12 | Gift | 110,000 | -- | -- | (1%) 8.74M to 8.63M | |
| 30-Jul-12 12:27 PM View: | Ehrlich Leo Chief Executive Officer Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 27-Jul-10 | Acquisition (other) | 1,000,000 | -- | -- | 9% 11.25M to 12.25M | |
| 30-Jul-12 1:30 PM View: | Menon Krishna President, CSO Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 27-Jul-10 | Purchase | 1,000,000 | -- | -- | (2%) 64.1M to 63.1M | |
| 30-Jul-12 1:30 PM View: | Menon Krishna President, CSO Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 10-Oct-09 | Acquisition (other) | 32,048,300 | -- | -- | 52% 62.1M to 94.14M | |
| 30-Jul-12 1:30 PM View: | Menon Krishna President, CSO Director 10% Owner | Innovation Pharmaceuticals ... (IPIX) | 10-Oct-09 | Disposition (other) | 32,048,300 | -- | -- | (34%) 94.14M to 62.1M |
